ORMP return on assets is -30.50%. Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) quarterly performance is -5.61%. BluePhoenix Solutions Ltd. (NASDAQ:BPHX) Wednesday said it has entered into a definitive merger agreement with Sophisticated Business Systems, Inc., or ATERAS, pursuant to which Ateras and a wholly-owned subsidiary of BluePhoenix would merge. The agreement is an all-stock transaction in which BluePhoenix will issue approximately 6.2 million shares to ATERAS shareholders in exchange for 100 percent of ATERAS' shares. On 13 August, BluePhoenix Solutions Ltd. (NASDAQ:BPHX) shares advanced 1.78% and was closed at $4.00. BPHX EPS growth in last 5 year was -51.10%. BluePhoenix Solutions Ltd. (NASDAQ:BPHX) year to date (YTD) performance is -13.04%.